These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 38238059

  • 21. Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
    Punja S, Shamseer L, Hartling L, Urichuk L, Vandermeer B, Nikles J, Vohra S.
    Cochrane Database Syst Rev; 2016 Feb 04; 2(2):CD009996. PubMed ID: 26844979
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF, Miller A, Fine S.
    Pediatrics; 2004 Nov 04; 114(5):e541-7. PubMed ID: 15520087
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Prevalence of type 2 diabetes, prediabetes, and gestational diabetes mellitus in women of childbearing age in Middle East and North Africa, 2000-2017: protocol for two systematic reviews and meta-analyses.
    Al-Rifai RH, Aziz F.
    Syst Rev; 2018 Jul 18; 7(1):96. PubMed ID: 30021654
    [Abstract] [Full Text] [Related]

  • 27. Long-term Trends in Hypertension Prevalence, Awareness, Treatment, and Control Rate in the Middle East and North Africa: a Systematic Review and Meta-analysis of 178 Population-Based Studies.
    Mohammadian Khonsari N, Shahrestanaki E, Ejtahed HS, Djalalinia S, Sheidaei A, Hakak-Zargar B, Heshmati J, Mahdavi-Gorabi A, Qorbani M.
    Curr Hypertens Rep; 2021 Oct 08; 23(9):41. PubMed ID: 34625888
    [Abstract] [Full Text] [Related]

  • 28. Attention-deficit hyperactivity disorder symptoms in a clinic sample of children and adolescents with pervasive developmental disorders.
    Lee DO, Ousley OY.
    J Child Adolesc Psychopharmacol; 2006 Dec 08; 16(6):737-46. PubMed ID: 17201617
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
    Gillies D, Sinn JKh, Lad SS, Leach MJ, Ross MJ.
    Cochrane Database Syst Rev; 2012 Jul 11; 2012(7):CD007986. PubMed ID: 22786509
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Prevalence and Risk Factors Associated With Attention-Deficit/Hyperactivity Disorder Among US Black Individuals: A Systematic Review and Meta-analysis.
    Cénat JM, Blais-Rochette C, Morse C, Vandette MP, Noorishad PG, Kogan C, Ndengeyingoma A, Labelle PR.
    JAMA Psychiatry; 2021 Jan 01; 78(1):21-28. PubMed ID: 32902608
    [Abstract] [Full Text] [Related]

  • 35. Prevalence of attention deficit hyperactivity disorder among children and adolescents in Spain: a systematic review and meta-analysis of epidemiological studies.
    Catalá-López F, Peiró S, Ridao M, Sanfélix-Gimeno G, Gènova-Maleras R, Catalá MA.
    BMC Psychiatry; 2012 Oct 12; 12():168. PubMed ID: 23057832
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Prevalence of attention-deficit hyperactivity disorder in adult prisoners: An updated meta-analysis.
    Fazel S, Favril L.
    Crim Behav Ment Health; 2024 Jun 12; 34(3):339-346. PubMed ID: 38568877
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.